Previous 10 | Next 10 |
Biotricity (NASDAQ: BTCY) is reforming the health care market by bridging the gap in remote monitoring and chronic care management. Biotricity was recently named to Fast Company’s annual list of the world’s most innovative companies for 2022 alongside Canva, Microsoft and Spa...
Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technol...
Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position Biotricity now taking preorders for Biotres, an FDA-cleared, wireless, wearable cardiac arrhythmia monitoring device REDWOOD CITY, CA / ACCESSWIRE / Marc...
Announcement follows FDA clearance Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology...
Biotricity, Inc. (BTCY) Q3 2022 Earnings Conference Call February 15, 2022 4:15 PM ET Company Participants Waqaas Al-Siddiq – Chairman, Chief Executive Officer and Founder John Ayanoglou – Chief Financial Officer Conference Call Participants Allen Klee – Maxim Group Tim M...
Biotricity press release (NASDAQ:BTCY): FQ3 Non-GAAP EPS of -$0.12. Revenue of $1.93M (+93.0% Y/Y). For further details see: Biotricity Non-GAAP EPS of -$0.12, revenue of $1.93M
Management to host investor call on Tuesday February 15th at 4:15 pm ET 93% YOY Revenue Gains to $1.93 Million Revenue Outpaces SG&A Increase by 2.2x Cash Position of $16.8 Million at Quarter End Is Highest Ever Continues to Anticipate Full-Year Triple-Digit Revenue Growth ...
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements Fourth Quarter 2021 Financial Results to be Announced in March PR Newswire DALLAS , Feb. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life s...
Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE / February 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),...
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion -dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a ...
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...